Clinically and ethically relevant questions are related to patient safety, therapeutic efficacy, equitable access, and global governance over humanity’s genetic legacy.
AMA J Ethics. 2019;21(12):E1079-1088. doi:
10.1001/amajethics.2019.1079.
Gene editing reminds professionals and the public that this technology’s reach goes beyond treating somatic disease to germline consequences yet unknown.
AMA J Ethics. 2019;21(12):E1056-1058. doi:
10.1001/amajethics.2019.1056.
The DSM-5 Task Force’s handling of the ethical controversy over the bereavement exclusion demonstrates the need for more inclusive deliberative processes.
AMA J Ethics. 2017;19(2):192-198. doi:
10.1001/journalofethics.2017.19.2.pfor2-1702.
We live in a time when an array of information is available at the fingertips of anyone with access to a computer, but more information doesn’t necessarily mean more understanding. False beliefs about health care can be quickly and widely perpetuated online, with serious consequences. This month on Ethics Talk, we spoke with Dr. Jennifer McCormick, Dr. Albert Ko, and Dr. Diane Griffin about why it’s important for clinicians to respond to health care-related false beliefs and how they can do so effectively.
In a special mini-episode of Ethics Talk, we explore the implications of a new proposed immigration policy that could have broad effects on immigrants' health with Dr. Rachel Fabi, explain why clinicians and students should consider submitting a public comment, and outline best practices for weighing in.
Women who are pregnant might not treat their mental illnesses because they overestimate risks of medication and underestimate risks of leaving their illness untreated.
AMA J Ethics. 2016;18(6):614-623. doi:
10.1001/journalofethics.2016.18.6.stas1-1606.
Shared decision making honors patient autonomy, particularly for preference-sensitive care decisions and even when patients have impaired decision-making capacity.
AMA J Ethics. 2020;22(5):E358-364. doi:
10.1001/amajethics.2020.358.